Search results for " Rectal"

showing 10 items of 56 documents

Food Hypersensitivity as a Cause of Rectal Bleeding in Adults

2008

Background & Aims Rectal bleeding and lymphonodular hyperplasia (LNH) in children can be caused by food hypersensitivity (FH). Our aim was to verify whether similar clinical and endoscopy presentations in adults can be due to FH. Methods Consecutive adult patients with rectal bleeding were enrolled. All underwent routine assays, colonoscopy, and histology study. Results Ten of 64 (15%) patients showed LNH as the unique sign at colonoscopy. An oligoantigenic diet resolved the rectal bleeding in 9 patients, and the reintroduction of several foods caused symptom reappearance. Double-blind placebo-controlled challenges with cow's milk and wheat protein confirmed the FH; symptoms reappeared 1–96…

Adultmedicine.medical_specialtyFood hypersensitivitySettore MED/09 - Medicina InternaColonoscopyHemorrhageRecurrent rectal bleedingIleumWheat HypersensitivityFood hypersensitivity; rectal bleeding; adultsGastroenterologyPlacebosDouble-Blind MethodRecurrenceInternal medicineadultsmedicineHumansIntestinal MucosaChildrectal bleedingAgedLamina propriaHyperplasiaHepatologymedicine.diagnostic_testHistocytochemistrybusiness.industryGastroenterologyfood and beveragesHistologyColonoscopyImmunoglobulin EMiddle AgedHyperplasiamedicine.diseaseFood hypersensitivityEndoscopyRectal Diseasesmedicine.anatomical_structureLymph NodesMilk HypersensitivitybusinessClinical Gastroenterology and Hepatology
researchProduct

FISSIT (Fistula Surgery in Italy) study: A retrospective survey on the surgical management of anal fistulas in Italy over the last 15 years

2021

Background: Surgical treatment of anal fistulas is still a challenge. The aims of this study were to evaluate the adoption and healing rates for the different surgical techniques used in Italy over the past 15 years. Methods: This was a multicenter retrospective observational study of patients affected by simple and complex anal fistulas of cryptoglandular origin who were surgically treated in the period 2003–2017. Surgical techniques were grouped as sphincter-cutting or sphincter-sparing and as technology-assisted or techno-free. All patients included in the study were followed for at least 12 months. Results: A total of 9,536 patients (5,520 simple; 4,016 complex fistulas) entered the stu…

Anal fistulaMalemedicine.medical_specialtyCure rateFistulaSettore MED/18 - CHIRURGIA GENERALEAnal CanalAnal Canal; Fecal Incontinence; Female; Follow-Up Studies; Humans; Incidence; Italy; Male; Middle Aged; Population Surveillance; Postoperative Complications; Rectal Fistula; Retrospective Studies; ForecastingFistulotomyFollow-Up StudiePostoperative ComplicationsRetrospective surveyRetrospective StudiemedicineHumansRectal FistulaAnal fistulaSurgical treatmentRetrospective Studiesanorectal fistulabusiness.industryIncidenceRetrospective cohort studyMiddle Agedmedicine.diseaseSurgerySettore MED/18ItalyPopulation SurveillanceSurgeryFemalePostoperative ComplicationbusinessFecal IncontinenceHumanFollow-Up StudiesForecasting
researchProduct

Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy.

2011

Background Humanized murine models comprise a new tool to analyze novel therapeutic strategies for allergic diseases of the intestine. Objective In this study we developed a human PBMC–engrafted murine model of allergen-driven gut inflammation and analyzed the underlying immunologic mechanisms. Methods Nonobese diabetic (NOD)– scid -γc −/− mice were injected intraperitoneally with human PBMCs from allergic donors together with the respective allergen or not. Three weeks later, mice were challenged with the allergen orally or rectally, and gut inflammation was monitored with a high-resolution video miniendoscopic system, as well as histologically. Results Using the aeroallergens birch or gra…

CD4-Positive T-LymphocytesAllergymedicine.medical_treatmentImmunologyHistamine AntagonistsAdministration OralInflammationNodMice SCIDPlatelet Membrane GlycoproteinsBiologymedicine.disease_causeImmunoglobulin ELymphocyte ActivationReceptors G-Protein-Coupledchemistry.chemical_compoundMiceAllergenimmune system diseasesAdministration RectalAntibody Specificityotorhinolaryngologic diseasesmedicineHypersensitivityImmunology and AllergyAnimalsHumansColitisMice KnockoutReceptors IgEAllergensImmunoglobulin Emedicine.diseaseDisease Models AnimalCytokinechemistryGastritisImmunologybiology.proteinLeukocytes MononuclearCytokinesPollenmedicine.symptomHistamineSpleenThe Journal of allergy and clinical immunology
researchProduct

EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe

2013

Contains fulltext : 125368.pdf (Publisher’s version ) (Closed access) BACKGROUND: Care for patients with colon and rectal cancer has improved in the last twenty years however still considerable variation exists in cancer management and outcome between European countries. Therefore, EURECCA, which is the acronym of European Registration of cancer care, is aiming at defining core treatment strategies and developing a European audit structure in order to improve the quality of care for all patients with colon and rectal cancer. In December 2012 the first multidisciplinary consensus conference about colon and rectum was held looking for multidisciplinary consensus. The expert panel consisted of…

Cancer ResearchDelphi TechniqueColorectal cancerDelphi methodPhysician's Practice PatternsGUIDELINESSTAGESurgical oncologyMinimal invasive surgeryTeams in the workplacePractice Patterns Physicians'Rectal cancerCooperative BehaviorSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAddc:616Neoadjuvant radiotherapyMultidisciplinary teamTranslational research Tissue engineering and pathology [ONCOL 3]Total mesorectal excisionQuality assuranceColon cancerNeoadjuvant chemoradiotherapyEuropeColon cancer; Consensus; Delphi method; Minimal invasive surgery; Multidisciplinary team; Neoadjuvant chemoradiotherapy; Neoadjuvant radiotherapy; Quality assurance; Rectal cancerTreatment OutcomeOncologySURVIVALGuideline AdherenceColorectal NeoplasmsEuropaEUROCARECare of the sickCOUNTRIESmedicine.medical_specialtyMARGINEvidence-based practiceConsensusDelphi methodAuditDIAGNOSISSDG 3 - Good Health and Well-beingCàncer colorectalTreball en equipmedicineHumansCura dels malaltsPREOPERATIVE RADIOTHERAPYQuality of Health CarePatient Care Teambusiness.industryTOTAL MESORECTAL EXCISIONCancerAuditmedicine.diseaseColorectal cancerSurgeryOncology nursingFamily medicineREGISTRYInterdisciplinary Communicationbusiness
researchProduct

EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.

2014

Contains fulltext : 137861.pdf (Publisher’s version ) (Closed access) BACKGROUND: Care for patients with colon and rectal cancer has improved in the last 20years; however considerable variation still exists in cancer management and outcome between European countries. Large variation is also apparent between national guidelines and patterns of cancer care in Europe. Therefore, EURECCA, which is the acronym of European Registration of Cancer Care, is aiming at defining core treatment strategies and developing a European audit structure in order to improve the quality of care for all patients with colon and rectal cancer. In December 2012, the first multidisciplinary consensus conference about…

Cancer ResearchQuality Assurance Health CareColorectal cancerCancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2]Delphi methodSurgical oncologyFAMILIAL ADENOMATOUS POLYPOSISTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]MedicineSHORT-COURSE RADIOTHERAPYRectal cancerQuality assurance; Colon cancer; Rectal cancer; Multidisciplinary teams; Consensus; Delphi method; Audit; Neoadjuvant treatment; Adjuvant treatment; SurgerySettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIADisease ManagementPHASE-III TRIALRANDOMIZED CONTROLLED-TRIALNeoadjuvant TherapyQuality assuranceColon cancerEuropemedicine.anatomical_structureTreatment OutcomeOncologyTRANSANAL ENDOSCOPIC MICROSURGERYColonic NeoplasmsPractice Guidelines as TopicHYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPYmedicine.medical_specialtyNeoadjuvant treatmentEvidence-based practiceConsensusLYMPH-NODE EVALUATIONDelphi methodRectumAuditSDG 3 - Good Health and Well-beingHumansCIRCUMFERENTIAL RESECTION MARGINddc:610business.industryRectal NeoplasmsTOTAL MESORECTAL EXCISIONCancerLONG-TERM SURVIVALAuditAdjuvant treatmentmedicine.diseaseSurgeryOncology nursingFamily medicineSurgeryMultidisciplinary teamsbusiness
researchProduct

Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure

1999

BACKGROUND/AIMSReplication deficient recombinant adenoviruses represent an efficient means of transferring genes in vivo into a wide variety of dividing and quiescent cells from many different organs. Although the gastrointestinal tract is a potentially attractive target for gene therapy approaches, only a few studies on the use of viral gene transfer vehicles in the gut have been reported. The prospects of using recombinant adenoviruses for gene delivery into epithelial and subepithelial cells of the normal and inflamed colon are here analysed.METHODSAn E1/E3 deleted recombinant adenovirus (denoted AdCMVβGal) and an adenovirus with modified fibre structure (denoted AdZ.F(pk7)) both express…

ColonT cellGenetic enhancementGenetic VectorsGene ExpressionBiologyGene deliverymedicine.disease_causeRecombinant virusArticleAdenoviridaeMiceAdministration RectalGene expressionmedicineAnimalsHumansReporter geneLamina propriaMice Inbred BALB CGastroenterologyGene Transfer TechniquesDefective VirusesColitisInflammatory Bowel Diseasesbeta-GalactosidaseVirologyMolecular biologyAdenoviridaemedicine.anatomical_structureInjections IntravenousInjections Intraperitoneal
researchProduct

A Predictive System to Classify Preoperative Grading of Rectal Cancer Using Radiomics Features

2022

Although preoperative biopsy of rectal cancer (RC) is an essential step for confirmation of diagnosis, it currently fails to provide prognostic information to the clinician beyond a rough estimation of tumour grade. In this study we used a risk classification to stratified patient in low-risk and high-risk patients in relation to the disease free survival and the overall survival using histopathological post-operative features. The purpose of this study was to evaluate if low-risk and high-risk RC can be distinguished using a CT-based radiomics model. We retrospectively reviewed the preoperative abdominal contrast-enhanced CT of 40 patients with RC. CT portal-venous phase was used for manua…

Computed tomography Radiomics Rectal cancer Texture analysis
researchProduct

Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes.

2007

In this work we show that the percentage of Ki-RAS mutations in codons 12 and 13 in rectal cancer are sensibly lower than in colon cancer, providing further evidence that these two kinds of tumors should be considered two different entities. Moreover, we show that the detection in regional lymph nodes of the same mutation of primary tumor might represent an indicator of lymph nodes metastasis in rectal carcinoma not detected in routine histologic examination.

KI-RAS MUTATIONS Rectal carcinomasSettore MED/06 - Oncologia MedicaSettore MED/08 - Anatomia Patologica
researchProduct

The impact of conversion on the risk of major complication following laparoscopic colonic surgery: an international, multicentre prospective audit.

2018

BACKGROUND: Laparoscopy has now been implemented as a standard of care for elective colonic resection around the world. During the adoption period, studies showed that conversion may be detrimental to patients, with poorer outcomes than both laparoscopic completed or planned open surgery. The primary aim of this study was to determine whether laparoscopic conversion was associated with a higher major complication rate than planned open surgery in contemporary, international practice.METHODS: Combined analysis of the European Society of Coloproctology 2017 and 2015 audits. Patients were included if they underwent elective resection of a colonic segment from the caecum to the rectosigmoid jun…

Laparoscopic surgeryMaleColorectal cancermedicine.medical_treatmentsurgery0302 clinical medicinePostoperative ComplicationsMedicineMajor complicationProspective StudiesLaparoscopySHORT-TERM OUTCOMESColectomyMedical Auditmedicine.diagnostic_testProspective auditGastroenterologyMiddle Agedlaparoscopic surgeryConversion to Open SurgeryColon cancerTreatment OutcomeElective Surgical Procedures030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleColonic surgeryAdultmedicine.medical_specialtyCLINICAL-TRIALNOOPEN COLECTOMY03 medical and health sciencesCOLORECTAL SURGERYCase mix indexgastrointestinal surgeryHumansrectal cancerRECTAL-CANCERAgedta3126business.industryElective resectionmedicine.diseaseRANDOMIZED-TRIALOPEN RESECTIONSurgeryColon cancer; gastrointestinal surgery; laparoscopic surgery; rectal cancer; surgery; GastroenterologyLaparoscopybusinessColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
researchProduct

γδ T cells and their clinical application in colon cancer

2023

In recent years, research has focused on colorectal cancer to implement modern treatment approaches to improve patient survival. In this new era, γδ T cells constitute a new and promising candidate to treat many types of cancer because of their potent killing activity and their ability to recognize tumor antigens independently of HLA molecules. Here, we focus on the roles that γδ T cells play in antitumor immunity, especially in colorectal cancer. Furthermore, we provide an overview of small-scale clinical trials in patients with colorectal cancer employing either in vivo activation or adoptive transfer of ex vivo expanded γδ T cells and suggest possible combinatorial approaches to treat co…

MHC- unrestricted activationtumorcolon rectal cancerImmunologyImmunology and Allergygamma delta T cellsimmunotherapy
researchProduct